New paper from PLRC, @unibern, and @visible_health!
We asked: What factors lead to changes in symptoms after reinfections?
Short answer: Increased physical activity, health crashes, and lower functional baseline — right before an infection — lead to more severe symptoms. 1/l
@AlexHarding7 We've been here before with genomics and 'cures by 2020'. I think AI is a powerful research tool, but biology doesn't bend to a product roadmap or an IPO timeline.
@Latinamd@IASLC@SylvesterCancer Safe travels! I think most progress in lung cancer screening and diagnostics comes from exactly these kinds of cross-border exchanges, not any single health system.
#socialism Make no mistake... this is Canada and the UK. It is a shitshow. It is not healthcare... it is a tax funded jobs program that sucks excellence, productivity, accountability, and innovation out of healthcare (and it is more expensive). Government has already started doing to healthcare as they did with education. Except this time... we get dumb and sick people.
@genophoria Nice chart. Though a lab grading its own homework always makes me cautious. I'd want to see that 46% hold up on independent medical benchmarks before calling it a frontier shift. The pace is real though.
This story moved me. Not long ago stage 4 lung cancer had very few options, and immunotherapy trials changed that. When clinical research gets funded properly, veterans get more time with the people they love.
A stage 4 lung cancer diagnosis changed retired Navy Commander John Ryan’s life. An immunotherapy clinical trial helped save his life.
This #VeteransDay, discover his story and how CRI-funded research is advancing cancer treatment for veterans: https://t.co/RkpiXbJbj3
@parthaskar Declining care isn't an accident, it's policy by neglect. Short-term politics keeps failing a system that needs long-term thinking. And no one in power will speak up because owning a problem this structural would end careers.
This is what functional public health infrastructure looks like. Fast case finding, isolation, contact tracing. I've said it before: basics done well beat any new technology in outbreak control.
Kenya discharged its last Ebola patient on Wednesday, starting a 42-day countdown to when the country can be declared free of the disease, Health Minister Aden Duale said. https://t.co/OX5vwiaFWT
@CarlosdelRio7@IDWeekmtg@PaulSaxMD Sax's IDWeek roundups are always worth reading. The new drugs are genuinely impressive, but the 'old diseases' framing is the real story: resistance and access are still where these breakthroughs stall.
@AUTOWAR25 Interesting list. Quite a bit of overlap between defense tech and medical applications these days. I keep an eye on triage, casualty care and comms tech because it flows straight into emergency care. Worth following even outside defense.
There's a balance to strike here. Emotional AI aimed at minors does worry me, especially in health contexts. But mandatory ID checks for adults feel heavy-handed, and nobody has answered the data retention question well.
New York wants to put friendliness behind an ID check. Under Hochul’s new law, a chatbot can’t flatter you, remember you, or say it’s happy for you until you show an ID. That’s a state speech code with an age gate attached. The First Amendment would like a word.
https://t.co/gNMXRFCmQ2
@cpgale3@ESC_Journals This is the right direction, simple bedside criteria for a diagnosis we can't afford to miss. But let's be real: specificity under 40% means the imaging burden doesn't go anywhere. Prospective testing is the make-or-break here.
$ABCL
Another Upgrade this morning by Goldman Sachs from $13 to $14.00 maintains a BUY HOLD
Just finished the $ABCL
Q3 earnings call.
it’s unbelievable the number of analysts who asked the same question said differently regarding ABCL992.
It’s a stronger formula that requires less frequent dosing and prevents the competition from eating their lunch.
Don’t sleep on it
🤖 One week to go!
Is your ophthalmology practice showing up in AI-powered search?
Join our webinar to discover how Google, reviews, and AI are changing patient discovery.
📅 Nov 18 | 4 PM EST | 1 PM PST
🔗 Register: https://t.co/3wS00PaFy4
#Ophthalmology
We are now enrolling to the #ERADICATE study!
This is a phase Ib/II study of #Elacestrant in combination with #TrastuzumabDeruxtecan (T-DXd) for patients with CDK4/6 inhibitor and endocrine-resistant HR+/HER2-low or HER2-ultralow metastatic #BreastCancer.
To learn more about the #ERADICATE study, call 877-338-7425 or visit https://t.co/SiyP47T6tI
PI: @KristinaFanucci #MetastaticBreastCancer #MBC #ClinicalTrial #BreastCancerResearch #TDXd
Congratulations to you and your residents! I've been following the GLP-1RA space closely, so that cytopenia abstract in particular caught my eye. Great to see mentorship paying off like this. Enjoy #ASH26 !
Going to #ASH26, and the news I'm happiest about isn't mine.
Three IM residents I mentor, Akshay Aluri, Michael Zargari and Pranay Shettywarangale, each won an ASH Abstract Achievement Award! So proud! 🧵1/4
@VUMCDiscoveries@jordanberlin5
This is the kind of tax I can actually support. It targets the behaviour driving 7 in 10 deaths, not people's income or work. Cutting tobacco use while funding universal coverage is prevention done properly.
7 in 10 deaths in the #Philippines are now caused by #NCDs noncommunicable diseases.
The Department of Health @DOHgovph is pushing for higher excise taxes on tobacco, alcohol and sugary products. It cites more than 95,000 deaths a year from #tobacco and about 27,000 from excessive #alcohol use.
The Philippines’ Sin Tax Reform has already shown that health #taxes cut consumption and help fund universal health care. Raising them further would protect both #health and revenue.
https://t.co/Ld4dRU91cG
Agreed. The moratorium push was always more about fear than substance. In healthcare it would have delayed tools that genuinely help clinicians. We still haven't struck the right balance between caution and progress.